MEDNAX, Inc. (MD) Tops Q1 EPS by 3c; Guides Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts MD Hot Sheet
Join SI Premium – FREE
MEDNAX, Inc. (NYSE: MD) reported Q1 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $382.3 million versus the consensus estimate of $378.64 million.
Sees Q211 EPS of $1.11 - $1.17, versus the consensus of $1.16.
Sees Q211 EPS of $1.11 - $1.17, versus the consensus of $1.16.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
